Access Your Free Trial of The Medical Letter
Stay current with The Medical Letter's critical appraisals of new prescription drugs and unbiased recommendations. Access The Medical Letter on Drugs and Therapeutics by signing up for a free trial.
The Medical Letter provides objective, practical, and timely information on drugs and treatments of common diseases to help medical professionals make the best decisions for their patients.
The Free Trial Subscription Includes:
  • Full online access to the Medical Letter: Includes access to past issues (1988 - present) and online only articles and tables
  • Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts
  • New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings
  • Consensus recommendations for the preferred and alternative treatments for common disorders
  • Comparative reviews of all of the drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
Get Free 30-Day Access

A valid email address is required. An email will be sent to this address with a special link for you to click on to activate this trial subscription.
The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients — without the influence of the pharmaceutical industry.

Many of our readers know that pharmaceutical companies and their representatives often exaggerate the therapeutic effects and understate the adverse effects of their products, but busy practitioners have neither the time nor the resources to check the accuracy of the manufacturers' claims. Our publication is intended specifically to meet the needs of busy healthcare professionals who want unbiased, reliable, and timely drug information. Our editorial process is designed to ensure that the information we provide represents an unbiased consensus of medical experts.
© 2018 The Medical Letter, Inc.     Terms & Conditions     Privacy & Security